MedTrace Logo

Tumor-Lymph Node Mapping

NCT07054944 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-04-23

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling.

This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.

Conditions

  • Pediatric Solid Tumors
  • Rhabdomyosarcoma
  • Sarcoma
  • Germ Cell Tumor

Interventions

DIAGNOSTIC_TEST

ICG (Indocyanine Green)

Lymphatic mapping

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-13
Primary Completion
2028-07-30
Completion
2028-07-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07054944 on ClinicalTrials.gov